Unrecognized peripartum cardiomyopathy in Haitian women

@article{Fett2005UnrecognizedPC,
  title={Unrecognized peripartum cardiomyopathy in Haitian women},
  author={J. Fett and L. Christie and R. D. Carraway and A. Ansari and J. B. Sundstrom and J. Murphy},
  journal={International Journal of Gynecology \& Obstetrics},
  year={2005},
  volume={90}
}
Objective: Haitian women have a high relative incidence of clinical presentation with peripartum cardiomyopathy (PPCM): an incidence estimated at one case per three hundred live births, a ten‐fold occurrence compared to American women. Our objective has been to test the hypothesis that some Haitian women may have a forme fruste of PPCM while still without clinical symptoms. Method: A preliminary case‐control study was conducted at the Hospital Albert Schweitzer (HAS), Deschapelles, Haiti, in… Expand
Reviewing peripartum cardiomyopathy: current state of knowledge.
TLDR
An overview on the clinical appearance and management, risk factors and potential pathophysiological mechanisms of PPCM, and pharmacological blockade of prolactin holds the promise of novel, more disease-specific therapy options. Expand
5 Peripartum Cardiomyopathy : A Systematic Review
Peripartum cardiomyopathy (PPCM) is a rare but potentially life-threatening condition that occurs in previously healthy women during the last month of pregnancy and up to 5-6 months postpartum. TheExpand
Peripartum Cardiomyopathy: A Systematic Review
TLDR
Because of its rare incidence, geographical differences, and heterogeneous presentation, PPCM continues to be incompletely characterized and understood, so future epidemiological trials and national registries are needed to learn more about the disease. Expand
Asymptomatic left ventricular dysfunction in puerperal women: an echocardiographic-based study.
TLDR
Asymptomatic left ventricular dysfunction in puerperal women shows a high prevalence and a pattern of long term echocardiographic changes similar to those found in overt peripartum cardiomyopathy. Expand
Peripartum cardiomyopathy: current understanding, comprehensive management review and new developments
TLDR
The medical management of PPCM is similar to other forms of non-ischaemic dilated cardiomyopathy, but with the management tailored to choose safe drugs in pregnancy and lactation to minimise maternal and fetal morbidity. Expand
Peripartum women with dyspnea in the emergency department
TLDR
Patients with PPCM had a higher heart rate, and the white blood cell, high-sensitivity C-reactive protein, and B-type natriuretic peptide levels were markedly elevated, whereas PaO2 and left ventricular ejection fraction (LVEF) were lower. Expand
Peripartum cardiomyopathy: An analysis of clinical profiles and outcomes from a tertiary care centre in southern India
TLDR
Peripartum cardiomyopathy with poor left ventricular ejection fraction and shock is associated with adverse maternal outcomes, while non-severe maternal anaemia predisposes to adverse fetal outcomes. Expand
Peripartum Cardiomyopathy: a Review for the Clinician
TLDR
An increase in oxidative stress and anti-angiogenic activity play key roles in the pathophysiology of peripartum cardiomyopathy andTherapies that target this dysregulation may have a future role in treatment. Expand
Pathophysiology and epidemiology of peripartum cardiomyopathy
TLDR
The latest understanding of the epidemiology, pathophysiology, and novel treatment strategies for patients with peripartum cardiomyopathy are described. Expand
Practical management of peripartum cardiomyopathy
TLDR
A multidisciplinary team approach is essential for acute HF, antepartum, labor and postpartum care, and recovery from left ventricular dysfunction is critical for prognosis. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 37 REFERENCES
Emerging insights into peripartum cardiomyopathy.
TLDR
Although the cause of PPCM and reasons for increased incidence in the HAS district of Haiti remain unknown, initial data present emerging insights and avenues to pursue in subsequent studies. Expand
Peripartum cardiomyopathy in the Hospital Albert Schweitzer District of Haiti.
TLDR
Peripartum cardiomyopathy appears to be relatively common in the Hospital Albert Schweitzer District of Haiti and a core group of patients is identified for ongoing epidemiologic and immunohematologic investigation of risk factors and potential etiologic factors. Expand
One hundred cases of peripartum cardiomyopathy... and counting: what is going on?
TLDR
Cardiac tissue exam from autopsy has demonstrated an inflammatory infiltrate in one of the three primiparas mentioned above, and in the HAS setting of high volume workload and limited resources cardiac catheterization and endomyocardial biopsy are not available. Expand
Is peripartum cardiomyopathy an organ-specific autoimmune disease?
TLDR
A more thorough study of the precise nature of the cardiac tissue autoantigens may lead to the identification of the mechanisms of breakdown of self-tolerance and perhaps also the putative etiologic agent(s). Expand
[Two cases of peripartum cardiomyopathy].
TLDR
These two cases suggest the importance of evaluation of endomyocardial biopsy to determine the degree of interstitial fibrosis that may reflect the prognosis for patients with peripartum cardiomyopathy confirmed by measurements of ejection fraction. Expand
A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography.
TLDR
A modified pharmacologic echocardiographic stress test is described that might be useful in determining left ventricular contractile reserve in women believed to be recovered by routine echOCardiographic studies, and the data may be useful when counseling women on future childbearing. Expand
Autoimmune mechanisms as the basis for human peripartum cardiomyopathy
TLDR
Findings for the first time suggest that such abnormalities may in concert lead to the initiation and perpetuation of an autoimmune process, which leads to cardiac failure and disease. Expand
Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1.
TLDR
Cytokine and sFas levels are elevated in patients with PPC, and despite treatment with ACE inhibitors and beta-blockers, mortality remains high, however, in 34% of the patients, left ventricular function almost completely normalized. Expand
Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review.
TLDR
Peripartum cardiomyopathy is a rare lethal disease about which little is known and diagnosis is confined to a narrow period and requires echocardiographic evidence of left ventricular systolic dysfunction. Expand
Impact of pregnancy-related heart failure on humoral immunity: clinical relevance of G3-subclass immunoglobulins in peripartum cardiomyopathy.
TLDR
In patients with peripartum cardiomyopathy, the impact of pregnancy-related HF on humoral immunity is not subclass-restricted, however, raised levels of IgG3s may be of prognostic value in clinical PPCM. Expand
...
1
2
3
4
...